The Therapeutic Goods Administration has issued a safety warning, saying it's "concerned" about an increase in the importation and supply of unapproved peptides. Significant TGA Fee Increases for Medical Devices in FY24 Commercial Eyes The TGA could reschedule MDMA and psilocybin what that means for ASX listers ASX:EMD The growing market for injectable peptides includes many schedule 4 drugs that are not yet approved for use in Australia but can be prescribed by a doctor Understanding Australia's Regulatory Framework Arena